Are endometrial stem cells novel tools against ischemic heart failure in women? A hypothesis

ABSTRACT

Recently stem cell therapy has suggested novel therapeutic strategies for management of heart failure and myocardial infarction. Our aim was to show that endometrial stromal cells produce a higher overall clonogenicity with a high angiogenesis potential. In addition, they may be converted into osteoblasts, odentoblasts, chindroblasts, neuroblasts and myoblasts and can be used for cell therapy as autologous and heterologous transplantations in future studies